Cresswell brings over 25 years of experience spanning diagnostics, pharmaceuticals, and medical devices. His background includes building commercial infrastructure for FDA-cleared diagnostics and leading precision oncology firms. At Perspectum, he will oversee the company's efforts to advance non-invasive imaging solutions for liver and cardiometabolic diseases, a sector where the company aims to accelerate drug development and improve patient outcomes.
In section Releases
Warren Cresswell Named CEO of Precision Health Firm Perspectum
Perspectum has appointed Warren Cresswell as its new Chief Executive Officer, tasking the veteran life sciences leader with guiding the Oxford-based company through its next phase of growth. The appointment, facilitated by executive search firm Slone Partners, follows Cresswell’s tenure as President and CEO of Prometheus Laboratories.
Leslie Loveless, CEO of Slone Partners, highlighted Cresswell’s track record in scaling organizations as a key asset for Perspectum’s technological expansion. Dr. Michael Rosenblatt, Chairperson of the Perspectum board, echoed this sentiment, noting that the board selected Cresswell specifically for his ability to translate scientific innovation into clinical impact. Cresswell holds a BA in Chemistry from California State University and an MBA from the University of Pittsburgh.
Comments (0)
No comments yet. Be the first!